Friday Pop Quiz #212
The correct answer is C. IL-36.
IL-36. Spesolimab is a novel, selective humanized anti–interleukin-36 receptor monoclonal antibody recently approved by the for the treatment of adults with GPP.1
IL-17 inhibitors approved for plaque psoriasis include secukinumab, ixekizumab, and brodalumab. Bimekizumab is also an IL-17 inhibitor in ongoing clinical trials for plaque psoriasis. IL-23 inh …